{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:16:35Z","timestamp":1785017795890,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,20]]},"DOI":"10.7759\/cureus.32749","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T19:05:33Z","timestamp":1671563133000},"source":"Crossref","is-referenced-by-count":5,"title":["Intricacies Affiliated With Post-COVID Vaccine Complications in Makkah Province, Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Muazzam M","family":"Sheriff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaher  G","family":"Basalib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya   J","family":"Mereani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layali M","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan  A","family":"Alzamzami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raha  M","family":"Garout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis - diagnosis, treatment options, and current controversies","volume":"12","author":"Pollack A","year":"2015","unstructured":"Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis - diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015, 12:670-80. 10.1038\/nrcardio.2015.108","journal-title":"Nat Rev Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60648-X","article-title":"Myocarditis","volume":"379","author":"Sagar S","year":"2012","unstructured":"Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet. 2012, 379:738-47. 10.1016\/S0140-6736(11)60648-X","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40588-021-00160-0","article-title":"Cardiovascular injury due to SARS-CoV-2","volume":"8","author":"Bugert CL","year":"2021","unstructured":"Bugert CL, Kwiat V, Valera IC, Bugert JJ, Parvatiyar MS. Cardiovascular injury due to SARS-CoV-2. Curr Clin Microbiol Rep. 2021, 8:167-77. 10.1007\/s40588-021-00160-0","journal-title":"Curr Clin Microbiol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.087","article-title":"Myocarditis following COVID-19 mRNA vaccination","volume":"39","author":"Abu Mouch S","year":"2021","unstructured":"Abu Mouch S, Roguin A, Hellou E, et al.. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021, 39:3790-3. 10.1016\/j.vaccine.2021.05.087","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab926","article-title":"Myocarditis following coronavirus disease 2019 mRNA vaccine: a case series and incidence rate determination","volume":"75","author":"Perez Y","year":"2022","unstructured":"Perez Y, Levy ER, Joshi AY, et al.. Myocarditis following coronavirus disease 2019 mRNA vaccine: a case series and incidence rate determination. Clin Infect Dis. 2022, 75:e749-54. 10.1093\/cid\/ciab926","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/children8070607","article-title":"Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?","volume":"8","author":"Das BB","year":"2021","unstructured":"Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children (Basel). 2021, 8:607. 10.3390\/children8070607","journal-title":"Children (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021, 144:471-84. 10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2021.05.033","article-title":"Myocarditis following COVID-19 vaccination","volume":"16","author":"Albert E","year":"2021","unstructured":"Albert E, Aurigemma G, Saucedo J, Gerson DS. Myocarditis following COVID-19 vaccination. Radiol Case Rep. 2021, 16:2142-5. 10.1016\/j.radcr.2021.05.033","journal-title":"Radiol Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.08.012","article-title":"Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: a case report and literature review","volume":"38","author":"Sulemankhil I","year":"2022","unstructured":"Sulemankhil I, Abdelrahman M, Negi SI. Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: a case report and literature review. Cardiovasc Revasc Med. 2022, 38:117-23. 10.1016\/j.carrev.2021.08.012","journal-title":"Cardiovasc Revasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after COVID-19 vaccination in a large health care organization","volume":"385","author":"Witberg G","year":"2021","unstructured":"Witberg G, Barda N, Hoss S, et al.. Myocarditis after COVID-19 vaccination in a large health care organization. N Engl J Med. 2021, 385:2132-9. 10.1056\/NEJMoa2110737","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel","volume":"385","author":"Mevorach D","year":"2021","unstructured":"Mevorach D, Anis E, Cedar N, et al.. Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel. N Engl J Med. 2021, 385:2140-9. 10.1056\/NEJMoa2109730","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102205","article-title":"COVID-19 vaccine-induced myocarditis: case report with literature review","volume":"15","author":"Nassar M","year":"2021","unstructured":"Nassar M, Nso N, Gonzalez C, et al.. COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes Metab Syndr. 2021, 15:102205. 10.1016\/j.dsx.2021.102205","journal-title":"Diabetes Metab Syndr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2828","article-title":"Patients with acute myocarditis following mRNA COVID-19 vaccination","volume":"6","author":"Kim HW","year":"2021","unstructured":"Kim HW, Jenista ER, Wendell DC, et al.. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021, 6:1196-201. 10.1001\/jamacardio.2021.2828","journal-title":"JAMA Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2833","article-title":"Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military","volume":"6","author":"Montgomery J","year":"2021","unstructured":"Montgomery J, Ryan M, Engler R, et al.. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021, 6:1202-6. 10.1001\/jamacardio.2021.2833","journal-title":"JAMA Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002681","article-title":"COVID-19 mRNA vaccine and myocarditis","volume":"8","author":"Singh B","year":"2021","unstructured":"Singh B, Kaur P, Cedeno L, et al.. COVID-19 mRNA vaccine and myocarditis. Eur J Case Rep Intern Med. 2021, 8:002681. 10.12890\/2021_002681","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-053427","article-title":"COVID-19 vaccination-associated myocarditis in adolescents","volume":"148","author":"Jain SS","year":"2021","unstructured":"Jain SS, Steele JM, Fonseca B, et al.. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021, 148:e2021053427. 10.1542\/peds.2021-053427","journal-title":"Pediatrics"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26853","article-title":"Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents","volume":"218","author":"Chelala L","year":"2022","unstructured":"Chelala L, Jeudy J, Hossain R, Rosenthal G, Pietris N, White CS. Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. AJR Am J Roentgenol. 2022, 218:651-7. 10.2214\/AJR.21.26853","journal-title":"AJR Am J Roentgenol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.3471","article-title":"Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children","volume":"6","author":"Dionne A","year":"2021","unstructured":"Dionne A, Sperotto F, Chamberlain S, et al.. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021, 6:1446-50. 10.1001\/jamacardio.2021.3471","journal-title":"JAMA Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster ME","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, et al.. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022, 327:331-40. 10.1001\/jama.2021.24110","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000522216","article-title":"Incidence, clinical presentation, and management of myocarditis following mRNA-based COVID-19 vaccines: a brief report","volume":"147","author":"Saeed S","year":"2022","unstructured":"Saeed S, K\u00e4sk L, Rajani R, Larsen TH. Incidence, clinical presentation, and management of myocarditis following mRNA-based COVID-19 vaccines: a brief report. Cardiology. 2022, 147:406-12. 10.1159\/000522216","journal-title":"Cardiology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27501","article-title":"Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine","volume":"94","author":"Woo W","year":"2022","unstructured":"Woo W, Kim AY, Yon DK, et al.. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine. J Med Virol. 2022, 94:1566-80. 10.1002\/jmv.27501","journal-title":"J Med Virol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2022.06.011","article-title":"Is the mRNA COVID-19 vaccine safe in patients with a prior history of myocarditis?","author":"Shahid R","year":"2022","unstructured":"Shahid R, Tang WH, Klein AL, Kwon D, Amdani S. Is the mRNA COVID-19 vaccine safe in patients with a prior history of myocarditis?. J Card Fail. 2022, 10.1016\/j.cardfail.2022.06.011","journal-title":"J Card Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2022.07.031","article-title":"Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults","volume":"365","author":"Simone A","year":"2022","unstructured":"Simone A, Herald J, Chen A, Nayak R, Shen YA, Lee MS. Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults. Int J Cardiol. 2022, 365:41-3. 10.1016\/j.ijcard.2022.07.031","journal-title":"Int J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpccr.2022.100153","article-title":"Fulminant myocarditis in a patient with a lung adenocarcinoma after the third dose of modern COVID-19 vaccine. A case report and literature review","volume":"6","author":"Ter\u00e1n Brage E","year":"2022","unstructured":"Ter\u00e1n Brage E, Rold\u00e1n Ru\u00edz J, Gonz\u00e1lez Mart\u00edn J, et al.. Fulminant myocarditis in a patient with a lung adenocarcinoma after the third dose of modern COVID-19 vaccine. A case report and literature review. Curr Probl Cancer Case Rep. 2022, 6:100153. 10.1016\/j.cpccr.2022.100153","journal-title":"Curr Probl Cancer Case Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.medin.2020.12.001","article-title":"COVID-19 severity index: a predictive score for hospitalized patients","volume":"46","author":"Huespe I","year":"2020","unstructured":"Huespe I, Carboni Bisso I, Di Stefano S, Terrasa S, Gemelli NA, Las Heras M. COVID-19 severity index: a predictive score for hospitalized patients. Med Intensiva (Engl Ed). 2020, 46:98-101. 10.1016\/j.medin.2020.12.001","journal-title":"Med Intensiva (Engl Ed)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"Liang W","year":"2020","unstructured":"Liang W, Liang H, Ou L, et al.. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020, 180:1081-9. 10.1001\/jamainternmed.2020.2033","journal-title":"JAMA Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13406","article-title":"Acute myeloid leukaemia: challenges and real world data from India","volume":"170","author":"Philip C","year":"2015","unstructured":"Philip C, George B, Ganapule A, et al.. Acute myeloid leukaemia: challenges and real world data from India. Br J Haematol. 2015, 170:110-7. 10.1111\/bjh.13406","journal-title":"Br J Haematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.tmaid.2021.101989","article-title":"AZD1222 (Covishield) vaccination for COVID-19: experiences, challenges, and solutions in Nepal","volume":"40","author":"Sah R","year":"2021","unstructured":"Sah R, Shrestha S, Mehta R, et al.. AZD1222 (Covishield) vaccination for COVID-19: experiences, challenges, and solutions in Nepal. Travel Med Infect Dis. 2021, 40:101989. 10.1016%2Fj.tmaid.2021.101989","journal-title":"Travel Med Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147%2FIDR.S332354","article-title":"Adverse effects of the COVID-19 vaccine reported by lecturers and staff of Kabul University of Medical Sciences, Kabul, Afghanistan","volume":"14","author":"Azimi M","year":"2021","unstructured":"Azimi M, Dehzad WM, Atiq MA, et al.. Adverse effects of the COVID-19 vaccine reported by lecturers and staff of Kabul University of Medical Sciences, Kabul, Afghanistan. Infect Drug Resist. 2021, 14:4077-83. 10.2147%2FIDR.S332354","journal-title":"Infect Drug Resist"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e114","article-title":"Adverse events following immunization associated with coronavirus disease 2019 vaccination reported in the mobile vaccine adverse events reporting system","volume":"36","author":"Jeon M","year":"2021","unstructured":"Jeon M, Kim J, Oh CE, Lee JY. Adverse events following immunization associated with coronavirus disease 2019 vaccination reported in the mobile vaccine adverse events reporting system. J Korean Med Sci. 2021, 36:e114. 10.3346\/jkms.2021.36.e114","journal-title":"J Korean Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/127661-intricacies-affiliated-with-post-covid-vaccine-complications-in-makkah-province-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:55Z","timestamp":1707507955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/127661-intricacies-affiliated-with-post-covid-vaccine-complications-in-makkah-province-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.32749","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,20]]}}}